Cytek Biosciences, Inc. (CTKB) vs SS Innovations International, Inc. (SSII)
Cytek Biosciences, Inc. and SS Innovations International, Inc. are both Medical Devices companies. Cytek Biosciences, Inc. is the larger, with a market value of $744.8M against $591.4M — 1.3× the size. SS Innovations International, Inc. grew revenue faster over the last twelve months: 89.7% against 5.44%. SS Innovations International, Inc. has the higher net margin (−23.7% vs −39.0%) and the higher return on invested capital (−11.3% vs −46.4%). Across the 17 metrics below, Cytek Biosciences, Inc. leads on 9 and SS Innovations International, Inc. on 8.
Valuation
Profitability
| Metric | CTKB | SSII | Medical Devices median |
|---|---|---|---|
| Gross margin | 53.23% | 47.65% | 56.01% |
| Operating margin | (21.60%) | (15.80%) | (15.03%) |
| Net margin | (38.98%) | (23.73%) | (20.40%) |
| Free cash flow margin | (5.79%) | (34.76%) | (7.24%) |
| Return on equity | (23.04%) | (26.06%) | (15.32%) |
| Return on assets | (17.14%) | (14.89%) | (19.72%) |
| Return on invested capital | (46.36%) | (11.31%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack